379 related articles for article (PubMed ID: 23032963)
1. Hyperuricaemia: more than just a cause of gout?
Katsiki N; Karagiannis A; Athyros VG; Mikhailidis DP
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):397-402. PubMed ID: 23032963
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and renal effects of hyperuricaemia and gout.
Viazzi F; Leoncini G; Pontremoli R
Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
[TBL] [Abstract][Full Text] [Related]
3. Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality.
Pérez Ruiz F; Richette P; Stack AG; Karra Gurunath R; García de Yébenes MJ; Carmona L
RMD Open; 2019; 5(2):e001015. PubMed ID: 31673414
[TBL] [Abstract][Full Text] [Related]
4. The kidney in hyperuricemia and gout.
Mount DB
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):216-23. PubMed ID: 23318701
[TBL] [Abstract][Full Text] [Related]
5. Altered uric acid levels and disease states.
Kutzing MK; Firestein BL
J Pharmacol Exp Ther; 2008 Jan; 324(1):1-7. PubMed ID: 17890445
[TBL] [Abstract][Full Text] [Related]
6. Uric acid and oxidative stress: relative impact on cardiovascular risk?
Strazzullo P; Puig JG
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
[TBL] [Abstract][Full Text] [Related]
7. Association of serum uric acid with cardiovascular disease in rheumatoid arthritis.
Panoulas VF; Milionis HJ; Douglas KM; Nightingale P; Kita MD; Klocke R; Elisaf MS; Kitas GD
Rheumatology (Oxford); 2007 Sep; 46(9):1466-70. PubMed ID: 17644822
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of the CoLaus study to decipher the determinants of serum uric acid].
Bochud M; Vollenweider P; Waeber G
Rev Med Suisse; 2011 Nov; 7(315):2142, 2144-5. PubMed ID: 22187784
[TBL] [Abstract][Full Text] [Related]
9. Serum urate and incidence of kidney disease among veterans with gout.
Krishnan E; Akhras KS; Sharma H; Marynchenko M; Wu E; Tawk RH; Liu J; Shi L
J Rheumatol; 2013 Jul; 40(7):1166-72. PubMed ID: 23678154
[TBL] [Abstract][Full Text] [Related]
10. [Uric acid, cardiovascular events and renal dysfunction: a circumstantial connection?].
Petriş A; Cimpoeşu D; Petriş O; Costache I
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):407-12. PubMed ID: 23077928
[TBL] [Abstract][Full Text] [Related]
11. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?
Baker JF; Krishnan E; Chen L; Schumacher HR
Am J Med; 2005 Aug; 118(8):816-26. PubMed ID: 16084170
[TBL] [Abstract][Full Text] [Related]
12. Why focus on uric acid?
Johnson RJ
Curr Med Res Opin; 2015; 31 Suppl 2():3-7. PubMed ID: 26414730
[TBL] [Abstract][Full Text] [Related]
13. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
Fujimori S
Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
[TBL] [Abstract][Full Text] [Related]
14. [Calcium antagonists: current and future applications based on new evidence. The mechanisms on lowering serum uric acid level by calcium channel blockers].
Mizuta E; Hamada T; Igawa O; Shigemasa C; Hisatome I
Clin Calcium; 2010 Jan; 20(1):45-50. PubMed ID: 20048433
[TBL] [Abstract][Full Text] [Related]
15. Estimation of serum uric acid in cases of hyperuricaemia and gout.
Pokharel K; Yadav BK; Jha B; Parajuli K; Pokharel RK
JNMA J Nepal Med Assoc; 2011; 51(181):15-20. PubMed ID: 22335090
[TBL] [Abstract][Full Text] [Related]
16. [Hyperuricemia].
Slot O
Ugeskr Laeger; 1994 Apr; 156(16):2396-401. PubMed ID: 8009701
[TBL] [Abstract][Full Text] [Related]
17. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?
Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
Curr Vasc Pharmacol; 2011 Nov; 9(6):698-705. PubMed ID: 21388346
[TBL] [Abstract][Full Text] [Related]
18. The role of hyperuricemia and gout in kidney and cardiovascular disease.
Edwards NL
Cleve Clin J Med; 2008 Jul; 75 Suppl 5():S13-6. PubMed ID: 18822470
[TBL] [Abstract][Full Text] [Related]
19. [HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].
Schils R; Krzesinski JM
Rev Med Liege; 2016 May; 71(5):262-8. PubMed ID: 27337847
[TBL] [Abstract][Full Text] [Related]
20. Multicenter, open-label study of long-term administration of febuxostat (TMX-67) in Japanese patients with hyperuricemia including gout.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S50-6. PubMed ID: 21654270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
